SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                               ------------------


                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE

                         SECURITIES EXCHANGE ACT OF 1934



         Date of Report (Date of earliest event reported) June 4, 1998



                           Curative Health Services, Inc.
             (Exact name of registrant as specified in its charter)



 Minnesota                       000-19370                   41-1503914
(State or other jurisdiction    (Commission File Number)    (IRS Employer
 of incorporation)                                           Identification No.)


 150 Motor Parkway Hauppauge, NY                             11788-5145
(Address of principal executive offices)                    (Zip code)


 Registrant's telephone number, including area code:        (516)232-7000



                                 NOT APPLICABLE
         (Former name or former address, if changed since last report.)


                                       1
<PAGE>
                          



Item 5. Other Events.

        The  Registrant  issued the press  release on June 4, 1998  included as
        Exhibit 7(c)(2).


Item 7. Financial Statements and Exhibits.

        (a)(b) No financial  statements or proforma financial  information
               filed herein.

        (c)    Exhibits. The following Exhibit is filed as part of this Report:

               Item No.  Description

               7(c)(2)   Press Release dated June 4, 1998.



                                       2
<PAGE>


                                   SIGNATURES



Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.



                                     Curative Health Services, Inc.
                                    (Registrant)


                                     
 Date:  June 4, 1998            By:  /s/  John C. Prior
                                     ---------------------------------
                                     John C. Prior
                                     Senior Vice President/Finance and CFO



                                       3
<PAGE>


FOR IMMEDIATE RELEASE         Contact:    Bill Tella
                                          Curative Health Services
                                          516-232-7000

                                          Steve Schelhammer
                                          Accordant Health Services
                                          910-855-5870

                                          Alison Trollope x 224 (Investor)
                                          Heather Hennessy x 274 (Media)
                                          Noonan/Russo Communications, Inc.
                                          212-696-4455

            CURATIVE HEALTH SERVICES, INC. ANNOUNCES AGREEMENTS WITH
                         ACCORDANT HEALTH SERVICES, INC.
          - New Program to Expand Curative's Wound Care Service Line -

Hauppauge,  New York, June 4, 1998 - Curative  Health  Services,  Inc.  (Nasdaq:
CURE) today  announced  that it has signed a development  and license  agreement
with Accordant Health Services,  Inc., a private disease management  company. At
the same time,  Curative  announced that it has agreed to participate in a round
of venture  financing  in which it will invest $4 million  dollars in  Accordant
preferred stock.

As a strategic  partner,  Accordant has been licensed by Curative to develop and
market a wound care  disease  management  program  specific  for  payors,  which
include   Health   Maintenance    Organizations   (HMOs),   Preferred   Provider
Organizations  (PPOs),  and  insurance  companies.  This new disease  management
program will complement  Curative's existing wound care management program which
is currently offered primarily to hospital providers.

It is anticipated that under the new disease management program,  Accordant will
identify  people  with  chronic  wounds as well as those who are at high risk of
developing   chronic   wounds.   Using  existing  as  well  as  newly  developed
relationships   with  payors,   Accordant   will  offer  the  program  to  payor
subscribers.  Accordant will use its core competencies in disease management and
computer  monitoring  systems to  develop,  market,  and operate  this  Curative
program to payors in select areas.
                                     

                                       4
<PAGE>


At the same  time,  Curative  has  agreed  to  invest $4  million  in  Accordant
convertible  preferred  stock as part of a $7 million  round of venture  capital
financing. Curative will own approximately 11% of Accordant's outstanding equity
determined on a fully diluted basis. The proceeds of the venture  financing will
be used for general corporate purposes.

John Vakoutis,  President and Chief Executive Officer of Curative, stated, "This
development  and license  agreement with Accordant is important to our long term
managed care strategy.  By incorporating a wound care disease management program
specific  for payors  with our  existing  comprehensive  wound  care  management
program,  Curative will position itself to further expand its growth.  Accordant
is the right  company to partner with since it has a  commendable  reputation in
the  disease  management  industry.  In the  future,  other  programs  such as a
diabetes disease management program may be developed."

Steve Schelhammer,  President and Chief Executive Officer of Accordant,  stated,
"We are pleased that Curative  recognizes the value in  Accordant's  approach to
specialized disease management services.  The wound care expertise that Curative
already has  successfully  accumulated will complement the process of developing
and delivering these services."

Accordant's  primary disease management  products are dedicated to patients with
rare and complex diseases such as multiple sclerosis and cystic fibrosis and are
marketed to payors. The Company has recently signed contracts with several large
payors to manage individuals with one of their specialty diseases.

Accordant Health Services,  Inc., based in Greensboro,  NC, is a private disease
management  company developed with and supported by the nation's leading experts
on rare chronic disorders.  The Company's focus is on producing  significant and
measurable  benefits to patients,  providers and purchasers of healthcare  while
emphasizing data driven accountability.

Curative  Health  Services,  Inc., is a leading  disease  management  company in
chronic wound care. The Company provides a broad continuum of services to health
care providers  through a nationwide  network of wound care programs which offer
comprehensive, multi-disciplinary wound care.

                                     ###

Editor's Note:  This press release is available on http://www.noonanrusso.com
[{"type": "8-K", "sequence": "1", "description": "8-K", "secsgml_size_bytes": 7199}]
{"company-data": {"conformed-name": "CURATIVE HEALTH SERVICES INC", "cik": "0000874212", "assigned-sic": "8093", "irs-number": "411503914", "state-of-incorporation": "MN", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-19370", "film-number": "98642510"}, "business-address": {"street1": "14 RESEARCH WAY", "street2": "BOX 9052", "city": "EAST SETAUKET", "state": "NY", "zip": "11733-9052", "phone": "5166897000"}, "mail-address": {"street1": "14 RESEARCH WAY", "city": "EAST SETAUKET", "state": "NY", "zip": "11733"}, "former-company": {"former-conformed-name": "CURATIVE TECHNOLOGIES INC /MN", "date-changed": "19930328"}}
SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                               ------------------

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

         Date of Report (Date of earliest event reported) June 4, 1998

                           Curative Health Services, Inc.
             (Exact name of registrant as specified in its charter)

 Minnesota                       000-19370                   41-1503914
(State or other jurisdiction    (Commission File Number)    (IRS Employer
 of incorporation)                                           Identification No.)

 150 Motor Parkway Hauppauge, NY                             11788-5145
(Address of principal executive offices)                    (Zip code)

 Registrant's telephone number, including area code:        (516)232-7000

                                 NOT APPLICABLE
         (Former name or former address, if changed since last report.)

                                       1
Item 5. Other Events.

        The  Registrant  issued the press  release on June 4, 1998  included as
        Exhibit 7(c)(2).

Item 7. Financial Statements and Exhibits.

        (a)(b) No financial  statements or proforma financial  information
               filed herein.

        (c)    Exhibits. The following Exhibit is filed as part of this Report:

               Item No.  Description

               7(c)(2)   Press Release dated June 4, 1998.

                                       2
SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.

                                     Curative Health Services, Inc.
                                    (Registrant)

                                     
 Date:  June 4, 1998            By:  /s/  John C. Prior
                                     ---------------------------------
                                     John C. Prior
                                     Senior Vice President/Finance and CFO

                                       3
FOR IMMEDIATE RELEASE         Contact:    Bill Tella
                                          Curative Health Services
                                          516-232-7000

                                          Steve Schelhammer
                                          Accordant Health Services
                                          910-855-5870

                                          Alison Trollope x 224 (Investor)
                                          Heather Hennessy x 274 (Media)
                                          Noonan/Russo Communications, Inc.
                                          212-696-4455

            CURATIVE HEALTH SERVICES, INC. ANNOUNCES AGREEMENTS WITH
                         ACCORDANT HEALTH SERVICES, INC.
          - New Program to Expand Curative's Wound Care Service Line -

Hauppauge,  New York, June 4, 1998 - Curative  Health  Services,  Inc.  (Nasdaq:
CURE) today  announced  that it has signed a development  and license  agreement
with Accordant Health Services,  Inc., a private disease management  company. At
the same time,  Curative  announced that it has agreed to participate in a round
of venture  financing  in which it will invest $4 million  dollars in  Accordant
preferred stock.

As a strategic  partner,  Accordant has been licensed by Curative to develop and
market a wound care  disease  management  program  specific  for  payors,  which
include   Health   Maintenance    Organizations   (HMOs),   Preferred   Provider
Organizations  (PPOs),  and  insurance  companies.  This new disease  management
program will complement  Curative's existing wound care management program which
is currently offered primarily to hospital providers.

It is anticipated that under the new disease management program,  Accordant will
identify  people  with  chronic  wounds as well as those who are at high risk of
developing   chronic   wounds.   Using  existing  as  well  as  newly  developed
relationships   with  payors,   Accordant   will  offer  the  program  to  payor
subscribers.  Accordant will use its core competencies in disease management and
computer  monitoring  systems to  develop,  market,  and operate  this  Curative
program to payors in select areas.
                                     

                                       4
At the same  time,  Curative  has  agreed  to  invest $4  million  in  Accordant
convertible  preferred  stock as part of a $7 million  round of venture  capital
financing. Curative will own approximately 11% of Accordant's outstanding equity
determined on a fully diluted basis. The proceeds of the venture  financing will
be used for general corporate purposes.

John Vakoutis,  President and Chief Executive Officer of Curative, stated, "This
development  and license  agreement with Accordant is important to our long term
managed care strategy.  By incorporating a wound care disease management program
specific  for payors  with our  existing  comprehensive  wound  care  management
program,  Curative will position itself to further expand its growth.  Accordant
is the right  company to partner with since it has a  commendable  reputation in
the  disease  management  industry.  In the  future,  other  programs  such as a
diabetes disease management program may be developed."

Steve Schelhammer,  President and Chief Executive Officer of Accordant,  stated,
"We are pleased that Curative  recognizes the value in  Accordant's  approach to
specialized disease management services.  The wound care expertise that Curative
already has  successfully  accumulated will complement the process of developing
and delivering these services."

Accordant's  primary disease management  products are dedicated to patients with
rare and complex diseases such as multiple sclerosis and cystic fibrosis and are
marketed to payors. The Company has recently signed contracts with several large
payors to manage individuals with one of their specialty diseases.

Accordant Health Services,  Inc., based in Greensboro,  NC, is a private disease
management  company developed with and supported by the nation's leading experts
on rare chronic disorders.  The Company's focus is on producing  significant and
measurable  benefits to patients,  providers and purchasers of healthcare  while
emphasizing data driven accountability.

Curative  Health  Services,  Inc., is a leading  disease  management  company in
chronic wound care. The Company provides a broad continuum of services to health
care providers  through a nationwide  network of wound care programs which offer
comprehensive, multi-disciplinary wound care.

                                     ###

Editor's Note:  This press release is available on http://www.noonanrusso.com